Prot #AT13387-05: A Study of HSP90 Inhibitor AT13387 Alone and in Combination with Crizotinib in the Treatment of Non-small Cell Lung Cancer (NSCLC)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/15/132/15/19

Funding

  • Astex Pharmaceuticals, Inc. (Prot #AT13387-05)